New agents for the treatment of drug-resistant Mycobacterium tuberculosis
about
New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016).Binding and processing of β-lactam antibiotics by the transpeptidase LdtMt2 from Mycobacterium tuberculosis.Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.Imaging flow cytometry analysis of intracellular pathogens.Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.Rhodococcus erythropolis as a host for expression, secretion and glycosylation of Mycobacterium tuberculosis proteins.Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.Proteomic profile of Mycobacterium tuberculosis after eupomatenoid-5 induction reveals potential drug targets.Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity.Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions.DNA Replication in Mycobacterium tuberculosis.News on therapeutic management of MDR-tuberculosis: a literature review.Evaluation of the Mycobactericidal Effect of Thio-functionalized Carbohydrate Derivatives.Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli.An uncommon cause of sciatic pain: tuberculous osteomyelitis of the ischial tuberosity.Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells.Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance.Hit Generation in TB Drug Discovery: From Genome to Granuloma.Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents.DNA Replication Fidelity in the Mycobacterium tuberculosis Complex.Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter.Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.Identification of Serine 119 as an Effective Inhibitor Binding Site of M. tuberculosis Ubiquitin-like Protein Ligase PafA Using Purified Proteins and M. smegmatis.Narrow-Spectrum Antibacterial Agents.Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approachIdentification of -Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular AgentsChallenging the Drug-Likeness Dogma for New Drug Discovery in TuberculosisDrug-resistant tuberculosis: challenges and opportunities for diagnosis and treatmentChallenges and recent progress in drug discovery for tropical diseases
P2860
Q30243915-0D3DD240-2E58-4981-9202-1E0FBA27B506Q30397294-250B235E-2328-4427-B5F0-0BE7130E2845Q33901126-B3525545-2E54-4936-929E-7F1AADA563B6Q36136833-B82BFAFA-E012-436D-A607-624345B32AB6Q37358682-A6CC0EF1-8B7F-429B-B3DF-C50848555E72Q37595801-A668A4A7-29BB-4F36-A62E-85C1415D144EQ37720810-13DB2367-D9D8-4498-B99F-6DB21419EAA7Q38661355-1900F4EA-1E2A-436A-A170-54DCCEB6CC19Q38669601-6ABD7D3D-7F75-4DE4-BD66-901FCA06E750Q38751247-E26A3516-9841-4528-B23B-D7FA5836B96FQ39024197-80FE59A0-9EFF-4E92-82E8-9CE472074E0EQ39210590-1ED118A5-0F43-45F3-ACB8-F6B3B6159B8AQ39398924-DA6E1065-3764-45EF-AF36-D043454C61D9Q40199657-2053BE28-51A8-43DA-B108-AB3B44E0BE6BQ40371811-51AC386F-E3B2-49CE-9ECA-A636E152E3ADQ40377027-1A9F339A-B5DB-4A43-B7E6-B1319C004FC5Q41284011-14D7C7D6-157D-4FD7-B61D-DADA5D9BCCEAQ46271797-1A5478F8-08E0-4544-8604-724B29A95544Q46532888-31E5643E-3D47-4074-84A7-B2855E10BDA0Q47446710-62698478-02CE-4CC9-AF8C-219B6ED6D0D7Q47702665-6B9A8193-E13F-47FF-AFB7-13401481A0D9Q48371677-72BDDC19-DB3D-4B4C-9CB1-C511AE28487CQ50107946-D27D1C8B-803C-467C-AC65-E18E8AD18D6BQ52568342-BF36C84B-C0A1-4664-AB46-AFE894630960Q52584718-662A2610-66A1-42F4-B49E-C3C58292E8A9Q52684515-35B99169-09DE-44CD-9CAE-D8040C02A6DEQ53698033-F829C7F5-9FDF-470B-A37C-1C6E22DD7B3FQ53703028-45E6BE4A-0DCC-4E02-88C1-DE4DA7DA9049Q57093867-C1B1B1CF-F089-4B03-9119-DECE7C52A6B4Q57179149-CB656AC2-45CF-407A-BD25-6865C78B3B23Q57656314-4623EC13-4836-4655-8864-3CA7124A6E15Q58790087-190879DA-C70D-410B-9AC3-906555AB1E44Q59073293-99864A6C-70AB-4A5D-AC13-7B0E2C527E62
P2860
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@ast
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@en
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@nl
type
label
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@ast
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@en
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@nl
prefLabel
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@ast
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@en
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@nl
P2860
P1476
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
@en
P2093
Robin B Lee
P2860
P356
10.1016/J.ADDR.2016.04.026
P407
P577
2016-07-01T00:00:00Z